Cargando…
Immunological parameters as a new lead in the diagnosis of ovarian cancer
Ovarian cancer is the leading cause of pelvic gynecological cancer death in Europe. Prognosis is poor in women diagnosed at stage III to IV or in case disease recurs. Platin-based chemotherapy and radical surgery have already improved prognosis significantly. Novel strategies in the treatment of ova...
Autores principales: | Baert, T., Timmerman, D., Vergote, I., Coosemans, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Universa Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402445/ https://www.ncbi.nlm.nih.gov/pubmed/25897373 |
Ejemplares similares
-
A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?
por: Coosemans, A., et al.
Publicado: (2015) -
Ovarian cancer and the immune system
por: Baert, Thaïs, et al.
Publicado: (2017) -
The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer
por: Baert, Thaïs, et al.
Publicado: (2015) -
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
por: Fucikova, Jitka, et al.
Publicado: (2021) -
Treatment algorithm in patients with ovarian cancer
por: Vergote, I, et al.
Publicado: (2020)